Acuity Inc. Research Note: October 1 Tests a Divided Operating Mix
Acuity enters October 1 with Lighting under pressure, Intelligent Spaces growing quickly, and the operating mix still awaiting confirmation from results.
CAMS Research Desk
AYI: A mixed setup before the next earnings test
CAMS Premium research on Acuity.
CAMS Midday Market Check: September 24, 2026
Both official Nasdaq calendars support a regular United States trading session today.
Market Structure: Rates and Oil Test Market Breadth (September 24, 2026)
Rates and oil tighten the tape as broader equity weakness, a 5.11% 10-year yield, and preliminary radar evidence shape Thursday’s market test.
CAMS Morning Market Brief: September 24, 2026
Both official Nasdaq calendars support a regular United States trading session today.
Accenture Research Note: October 1 Tests Demand Breadth and Cash Resilience
Accenture enters October 1 with resilient margins and cash flow, while bookings and Consulting growth test whether demand can broaden across the business.
MKC: Margin quality meets combination risk
CAMS Premium research on McCormick.
CAMS Closing Market Recap: September 23, 2026
Treasury yields and oil climbed together, and stocks closed broadly lower.
ACN: Accenture at the October inflection point
CAMS Premium research on Accenture.
Celldex Therapeutics Research Note: Replicated Phase 3 Efficacy, Unfinished Commercial Proof
Celldex Therapeutics has replicated Phase 3 CSU efficacy, while longer-duration data, filing execution, and commercial proof remain unfinished.